The SOX6 gene encodes SRY-Box Transcription Factor 6, a protein involved in Transcription factor critical for neuronal development, myelination, and circadian rhythm regulation. This page provides comprehensive information about its structure, function, and role in neurodegenerative diseases.
| SOX6 (SRY-Box Transcription Factor 6) | |
|---|---|
| Official Symbol | SOX6 |
| Full Name | SRY-Box Transcription Factor 6 |
| Chromosomal Location | 11p15.3 |
| NCBI Gene ID | 55553 |
| OMIM | 607257 |
| Ensembl ID | ENSG00000110693 |
| UniProt ID | P35745 |
The SOX6 gene is an important component in the molecular pathways underlying neurodegenerative diseases. Understanding its function provides insights into disease mechanisms and potential therapeutic targets.
Transcription factor critical for neuronal development, myelination, and circadian rhythm regulation. This gene plays critical roles in normal physiological processes and its dysregulation contributes to pathological states in various neurodegenerative conditions.
SOX6 has been implicated in Alzheimer's disease pathogenesis through various mechanisms involving neuroinflammation, tau pathology, and synaptic dysfunction.
The gene is involved in dopaminergic neuron survival and mitochondrial function relevant to Parkinson's disease.
SOX6 alterations have been reported in ALS, FTD, and Huntington's disease.
Single nucleotide polymorphisms (SNPs) in SOX6 have been associated with disease risk and progression in neurodegenerative disorders.
SOX6 expression is altered in affected brain regions in neurodegenerative diseases, providing insights into its role in disease pathogenesis.
SOX6 interacts with various molecular pathways including:
SOX6-based therapeutic strategies are being explored for neurodegenerative diseases, including:
Understanding SOX6 function may lead to: